Schizophrenia Research
Volume 45, Issue 3 , Pages 245-260 , 27 October 2000

Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia

Received 21 May 1999 ,Accepted 10 October 1999.

References 

  1. APA . APA Diagnostic and Statistical Manual of Mental Disorders. third ed., revised. Washington, DC: APA; 1987;
  2. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989;27:335–350
  3. Chen EYH, Shapleske J, Luque R, McKenna PJ, Hodges JR, Calloway SP, et al. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res. 1995;56:183–204
  4. Convit A, Volavka J, Czobor P, Asis JD, Evangelista C. Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia. Am. J. Psychiatry. 1994;151:49–56
  5. Denckla MB. Revised neurological examination for subtle signs. Psychopharmacol. Bull. 1985;21:773–786
  6. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 1975;12:189–198
  7. Griffiths TD, Sigmundsson T, Takei N, Rowe D, Murray RM. Neurological abnormalities in familial and sporadic schizophrenia. Brain. 1998;121:191–203
  8. Gupta S, Andreassen NC, Arndt S, Flaum M, Schultz SK, Hubbard WC, et al. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am. J. Psychiatry. 1995;152:191–196
  9. Guy W. In: AIMS, ECDEU Assessment Manual for Psychopharmacology (ADM 76-338). Washington, DC: US Department of Health, Education and Welfare; 1976;p. 534–537
  10. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am. J. Psychiatry. 1988;145:11–18
  11. Ismail BT, Cantor-Graee E, McNeil TF. Neurological abnormalities in schizophrenic patients and their siblings. Am. J. Psychiatry. 1998;155:84–89
  12. Ismail BT, Cantor-Graae E, Cardenal S, Neil TFM. Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates. Schizophr. Res. 1998;30:229–238
  13. Kennard MA. Value of equivocal signs in neurologic diagnosis. Neurology. 1960;10:753–764
  14. King DJ, Wilson A, Cooper SJ, Waddington JL. The clinical correlates of neurological soft signs in chronic schizophrenia. Br. J. Psychiatry. 1991;158:770–775
  15. Liddle PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol. Med. 1987;17:49–57
  16. Malla AK, Norman RMG, Aguilar O, Cortese L. Relationship between neurological ‘soft signs’ and syndromes of schizophrenia. Acta Psychiatr. Scand. 1997;96:274–280
  17. Manschreck TC, Maher BA, Rucklos ME, Vereen DR. Disturbed voluntary motor activity in schizophrenic disorder. Psychol. Med. 1982;12:72–84
  18. Merriam AE, Kay SR, Opler LA, Kushner SF, vanPraag HM. Neurological signs and the positive–negative dimension in schizophrenia. Biol. Psychiatry. 1990;28:181–192
  19. Mohr F, Hubmann W, Cohen R, Bender W, Haslacher C, Hönicke S, et al. Neurological soft signs in schizophrenia: assessment and correlates. Eur. Arch. Psychiatry Clin. Neurosci. 1996;246:240–248
  20. Montgomery GK. Parkinson's disease and the Columbia scale. Neurology. 1984;34:557–558
  21. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9:97–113
  22. Overall JE, Gorham DR. The Brief Psychiatric Scale (BPRS). Psychol. Rep. 1962;10:799–812
  23. Quitkins F, Rifkin A, Klein DF. Neurologic soft signs in schizophrenia and character disorders. Arch. Gen. Psychiatry. 1976;33:845–853
  24. Rochford JM, Detre T, Tucher GJ, Harrow M. Neuropsychological impairments in functional psychiatric diseases. Arch. Gen. Psychiatry. 1970;22:114–119
  25. Rossi A, deCataldo S, diMichele V, Manna V, Ceccoli S, Stratta P, et al. Neurological soft signs in schizophrenia. Br. J. Psychiatry. 1990;157:735–739
  26. Sanders RD, Forman SD, Pierri JN, Baker RW, Kelley ME, Kammen DPV, et al. Inter-rater reliability of the neurological examination in schizophrenia. Schizophr. Res. 1998;29:287–292
  27. Schröder J, Niethammer R, Geider FJ, Reitz C, Binkert M, Jauss M, et al. Neurological soft signs in schizophrenia. Schizophr. Res. 1992;6:25–30
  28. Simpson GM, Angus JWS. A rating scale for extra-pyramidal side effects. Acta Psychiatr. Scand. (Suppl.). 1970;212:11–19
  29. Spitzer RL, Williams JB, Gibbon M, First MB. Instruction Manual for the Structured Clinical Interview for DSMIII-R (SCID 4/1/88 Rev.). New York: Biometric Research Department, New York State Psychiatric Institute; 1988;
  30. Walker E. Attentional and neuromotor functions of schizophrenics, schizoaffectives and patients with other affective disorders. Arch. Gen. Psychiatry. 1981;38:1355–1358
  31. Woods BT, Kinney DK, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar and substance abuse patients and normal controls. Arch. Gen. Psychiatry. 1986;43:657–663

PII: S0920-9964(99)00206-6

Schizophrenia Research
Volume 45, Issue 3 , Pages 245-260 , 27 October 2000

Article Tools

* Image Usage & Resolution